Researchers characterize three ways in which the gene FOXA1 mutates to trigger prostate cancer.

Cancer biologists and engineers collaborated on a device that could help predict the likelihood of breast cancer metastasis.

U-M researchers identify a potential treatment for non-alcoholic fatty liver disease.

Forty percent of people who develop venous thromboembolism don’t know what caused it. New research in mice further explores inflammation’s role.

Michigan-led research presents a new way of uncovering predictive biomarkers when data from large randomized trials aren’t available.

A 600-patient randomized clinical trial supports pembrolizumab and chemotherapy as a first-line treatment